Annual Report

Impact and Community

Last year, supporters like you helped fund cutting-edge research and programs designed to deliver community to patients with brain tumors and their caregivers. Your support also helped amplify our public policy agenda to ensure the urgent, unmet needs of the brain tumor community continue to be heard and addressed.

Highlights in the 2022 Annual Report include:

• Voices of patients, care partners, researchers, advocates, supporters, and other members of the brain tumor community 
• Brain tumor research grants that aim to propel new approaches to targeting the metabolism of glioblastoma (GBM) brain tumors and establish a new pipeline of promising meningioma treatments
• Launch of the DNA Damage Response Consortium, in partnership with Yale Cancer Center, which aims to rapidly advance a new class of promising potential treatments that can stop a crucial mechanism of how brain tumors grow
• Brain Tumor Investment Fund’s portfolio of well-qualified early-stage projects that hope to ultimately deliver transformational treatments and technologies to patients with brain tumors
• Advocacy and policy change, including an increase in federal funding for brain tumor research and the reauthorization of the Childhood Cancer STAR Act
• Expanded support for the brain tumor community, including a new grief support program
• Our Donor Honor Roll recognizes top fundraising teams and individuals, community events, corporate and foundation partners, and donors   

As you can see, your support last year made a profound impact. With your continued help, we will be the community that conquers and cures brain tumors — once and for all.